ARMANDO RIOS, JR. VS. MEDA PHARMACEUTICAL, INC. (L-0763-17, MORRIS COUNTY AND STATEWIDE)

New Jersey Superior Court Appellate Division·Decided July 1, 2020·No. A-3680-18T3·Unpublished

Opinion

NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION This opinion shall not "constitute precedent or be binding upon any court ." Although it is posted on the internet, this opinion is binding only on the parties in the case and its use in other cases is limited. R. 1:36-3.

SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION

DOCKET NO. A-3680-18T3

ARMANDO RIOS, JR., Plaintiff-Appellant,

v.

MEDA PHARMACEUTICAL, INC., TINA CHENG-AVERY, and GLENN GNIRREP,

Defendants-Respondents,

and MYLAN INC.,

Defendant.

Argued telephonically May 6, 2020 – Decided July 1, 2020

Before Judges Koblitz, Whipple, and Mawla.

On appeal from the Superior Court of New Jersey, Law Division, Morris County, Docket No. L-0763-17.

William R. Stoltz argued the cause for appellant (Law Offices Rosemarie Arnold, attorneys; Maria Luppino and William R. Stoltz, on the briefs).

John M. Losinger argued the cause for respondents (Wilson Sonsini Goodrich & Rosati, PC, and Saiber LLC, attorneys; Marina C. Tsatalis and John M.

Losinger, on the brief).

PER CURIAM Plaintiff Armando Rios, Jr. appeals from a March 20, 2019 summary judgment dismissal of his complaint against defendants Meda Pharmaceuticals, Inc. (Meda), Tina Cheng-Avery, and Glenn Gnirrep. We affirm.

Plaintiff, a Hispanic male, was hired in May 2015 in the Marketing Department at Meda after being personally interviewed by Tina Cheng-Avery, her supervisor Stuart Loesch, and other executives. Plaintiff's employment was "at will," meaning he could be terminated at any time with or without cause, which plaintiff acknowledged by signing the offer letter.

Cheng-Avery, who had recommended to Loesch that they hire plaintiff, was plaintiff's direct supervisor. Soon after plaintiff began working, she began documenting his performance, maintaining a document entitled "2015-2016 Performance Observations—Armando Rios." In it, she listed specific deficiencies with plaintiff's performance and the dates on which she met with

A-3680-18T3

plaintiff to counsel him on what she and Loesch believed he needed to do to improve his performance.

Plaintiff asserts that in the first few months of his employment, there were four events he contends constitute the basis of a hostile work environment claim. First, plaintiff asserted that in June 2015, while he and Cheng-Avery were alone in her office, he told her he and his wife were looking for a new home, to which she allegedly responded "it must be hard for a [s]pic to have to get FHA 1 loans." He claimed he shared the incident with Gnirrep, 2 the Director of Human Resources (HR), probably within twenty-four hours, but Gnirrep did not take notes, and plaintiff did not produce any written record of his own. Nor did plaintiff file a formal complaint, as he thought "speaking with [Gnirrep] would maybe initiate some procedures as he was the head of HR . . . . I was only in my role for a very short time so I was a little nervous and scared."

Plaintiff asserted he met with Gnirrep again about a month later after Cheng-Avery made a second comment while casting a role for a commercial that an actress "would work if she didn't look too [s]pic[-]y." The third incident plaintiff alleged was in September 2015; he asserted that while he was within

1 Federal Housing Administration.

2 Gnirrep passed away unexpectedly in August 2018 and was never deposed.

A-3680-18T3

earshot, Cheng-Avery made a comment to two of plaintiff's female co-workers, a peer and a subordinate, "about leveraging girl power, that girls gotta stick together to . . . solidarity to push the business forward." He alleged he told Gnirrep within twenty-four hours. The fourth incident occurred in late 2015, when plaintiff contends the same co-workers, and a third, told him that Cheng- Avery thought the men in certain departments were not as competent as the women.

In February 2016, after plaintiff's poor performance at a January 2016 marketing conference was reported to Cheng-Avery by both an internal employee and outside vendor Emerson Group, she and Loesch placed plaintiff on probation. They informed plaintiff he would be reevaluated at the end of May, but if they saw no immediate and substantial improvement before then he was subject to additional action, up to and including termination. Plaintiff wrote a memorandum responding to the alleged performance deficiencies point-by- point, which he asserted he delivered to Gnirrep to give to Cheng-Avery.

A month later, in March 2016, plaintiff received a negative year-end performance review and was given a detailed performance improvement plan. After weekly meetings with Cheng-Avery as part of this performance improvement plan, plaintiff improved only slightly over the next two months;

A-3680-18T3

an April 21 email indicated his level of improvement was unacceptable and reminded him he must show immediate and significant improvement.

At the end of May 2016, plaintiff asked to meet with Matt Holley, general counsel for Meda, to report that he believed Meda violated the Physicians Payment Sunshine Act (Sunshine Act) 3 for improper hiring on two occasions; he asserted he also had previously made a verbal report to Gnirrep as to one of those allegedly-improper hires in January 2016. The day after his meeting with Holley, plaintiff's employment was terminated by Cheng-Avery and Loesch.

Plaintiff filed a complaint in March 2017 and asserted claims under the Conscientious Employee Protection Act (CEPA), N.J.S.A. 34:19-1 to -14, for wrongful termination based on his Sunshine Act reports, and under the New Jersey Law Against Discrimination (NJLAD), N.J.S.A. 10:5-1 to -49, for harassment and hostile work environment based on his national origin and gender.

Plaintiff's complaint asserted five counts. Count one alleged that Cheng-

Avery, as his supervisor, created a hostile work environment by making

3 42 U.S.C. § 1320a-7h, enacted as part of the Affordable Care Act, requires pharmaceutical manufacturers that participate in federal health care programs to track and report payments and transfers of value given to physicians and teaching hospitals.

A-3680-18T3

comments about both his national origin and his gender—the two "spic" comments and the "girl power" reference—as well as by favoring female employees and calling male employees unworthy. Plaintiff alleged Cheng- Avery retaliated for his complaints to Gnirrep by taking staff away to ensure he was unable to perform his job, and also took job responsibilities away from plaintiff and assigned them to female employees to punish, embarrass, and humiliate him, as well as to discriminate against him because he is Hispanic and male.

Count two alleged Gnirrep had a duty to timely and fairly investigate plaintiff's complaints and take steps to prevent a hostile work environment and national origin and gender discrimination, but that he did not do so and rather allowed Cheng-Avery to remain in a supervisory role over plaintiff. Plaintiff contended Gnirrep told Cheng-Avery about his complaints, which made her discrimination and harassment of plaintiff worse.

Count three asserted Meda had a duty to have a well-publicized and effective training program and monitoring mechanism through which an anti- discrimination policy or anti-harassment policy could be enforced, and they failed to do so.

A-3680-18T3

Count four alleged plaintiff discovered Meda violated the Sunshine Act , and that when he reported this to Holley on May 31, 2016, he was subjected to retaliation by Meda, Cheng-Avery, and Gnirrep in that he was "wrongfully terminated the day after his report." Plaintiff contended there was a causal connection between his reporting and his termination. Count five alleged Cheng-Avery engaged in conduct to cause plaintiff severe emotional distress.

After the conclusion of discovery, defendants filed a motion for summary judgment. On March 20, 2019, after a hearing, the court granted defendants summary judgment on all counts and issued a thorough written decision. This appeal followed.

I.

Free access — add to your briefcase to read the full text and ask questions with AI

ARMANDO RIOS, JR. VS. MEDA PHARMACEUTICAL, INC. (L-0763-17, MORRIS COUNTY AND STATEWIDE), (N.J. Ct. App. 2020).

ARMANDO RIOS, JR. VS. MEDA PHARMACEUTICAL, INC. (L-0763-17, MORRIS COUNTY AND STATEWIDE) (ARMANDO RIOS, JR. VS. MEDA PHARMACEUTICAL, INC. (L-0763-17, MORRIS COUNTY AND STATEWIDE)) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Maimone v. City of Atlantic City
903 A.2d 1055 (Supreme Court of New Jersey, 2006)
Lehmann v. Toys 'R' US, Inc.
626 A.2d 445 (Supreme Court of New Jersey, 1993)
Godfrey v. Princeton Theological Seminary
952 A.2d 1034 (Supreme Court of New Jersey, 2008)
Zive v. Stanley Roberts, Inc.
867 A.2d 1133 (Supreme Court of New Jersey, 2005)
Kolb v. Burns
727 A.2d 525 (New Jersey Superior Court App Division, 1999)
El-Sioufi v. ST. PETER'S UNIV.
887 A.2d 1170 (New Jersey Superior Court App Division, 2005)
Dixon v. Rutgers, the State University of NJ
541 A.2d 1046 (Supreme Court of New Jersey, 1988)
Clowes v. Terminix International, Inc.
538 A.2d 794 (Supreme Court of New Jersey, 1988)
Dzwonar v. McDevitt
828 A.2d 893 (Supreme Court of New Jersey, 2003)
Green v. Jersey City Board of Education
828 A.2d 883 (Supreme Court of New Jersey, 2003)
Cutler v. Dorn
955 A.2d 917 (Supreme Court of New Jersey, 2008)
Taylor v. Metzger
706 A.2d 685 (Supreme Court of New Jersey, 1998)
Nadeau v. Rainbow Rugs, Inc.
675 A.2d 973 (Supreme Judicial Court of Maine, 1996)
Abbamont v. Piscataway Township Board of Education
650 A.2d 958 (Supreme Court of New Jersey, 1994)
Romano v. Brown & Williamson Tobacco
665 A.2d 1139 (New Jersey Superior Court App Division, 1995)
Bowles v. City of Camden
993 F. Supp. 255 (D. New Jersey, 1998)
Hancock v. Borough of Oaklyn
790 A.2d 186 (New Jersey Superior Court App Division, 2002)